Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib
A completed clinical trial evaluating change in disease activity in adolescents and adults with moderate-to-severe prurigo-type atopic derma…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis [Phase 2]
Phase 2 efficacy and safety trial of RPT193 in adults with atopic dermatitis was terminated; results have been posted.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
A pediatric study of dupilumab for atopic dermatitis in Spain is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Cross-Sectional Study for an Ocular Imaging-Based Predictive Model of Inflammatory Skin Diseases Grounded in Traditional Chinese Medicine
A clinical trial is planned to develop an ocular imaging-based predictive model of inflammatory skin diseases rooted in Traditional Chinese …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Flourish: Exploring the Early Infant Gut Microbiome [NA]
This clinical trial update describes Flourish, an early infant gut microbiome study sponsored by Seeding Inc, currently recruiting and exami…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema [Phase 2]
Pfizer is conducting a Phase 2 clinical trial to study PF-08049820 in people with atopic dermatitis (eczema); the study is currently active …
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases [NA]
This ClinicalTrials.gov update describes an ongoing study examining how environmental exposure to heavy metals, nanoparticles, and other con…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial assessing safety and efficacy of upadacitinib in combination with topical corticosteroids for children aged 2 to under 12 with…
-
CLINICAL_TRIALS other · 2026-02-23Clinical Trial Update: Phase 2 Trial of HY209gel in Atopic Dermatitis Patients [Phase 2]
A Phase 2 trial update for HY209gel in atopic dermatitis shows the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis [Phase 2]
This Phase 2 clinical trial evaluates the effectiveness and safety of treatments, alone or in combination, for moderate to severe atopic der…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis [Phase 4]
A Phase 4 study evaluating longitudinal endotyping of atopic dermatitis through transcriptomic analysis of skin has completed.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Systems Biology of Early Atopy
NIAID reports an ongoing clinical trial examining the systems biology of early atopy, focusing on allergic diseases and food allergy; the st…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
This is a Phase 2 study to evaluate the efficacy and safety of IMG-007 in adults with moderate-to-severe atopic dermatitis, currently recrui…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns. [NA]
ClinicalTrials.gov reports recruitment for a dietary supplement study using two Limosilactobacillus reuteri probiotic strains to prevent exc…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 proof-of-concept clinical trial evaluating IBI3002 in moderate-to-severe Atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis [Phase 2]
This clinical trial is evaluating two Pfizer investigational medicines (PF-07275315 and PF-07264660) for moderate to severe atopic dermatiti…
-
FDA approval · 2026-02-12FDA Approved: DIFAMILAST — Original Application (Acrotech Biopharma Inc)
FDA approved the original application for Difamilast (ADQUEY) from Acrotech Biopharma Inc. for the treatment of atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluating different doses of LEO 138559 in adults with moderate-to-severe atopic dermatitis has completed enrollment and re…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis [Phase 3]
This is a Phase 3 clinical trial update for ADSTEM Injection to treat moderate to severe subacute and chronic atopic dermatitis; the study i…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
A completed clinical trial evaluating adverse events and changes in disease symptoms in Korean participants with rheumatoid arthritis, atopi…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis
A real-world effectiveness study evaluating long-term dupilumab use in participants aged 6 years and older with atopic dermatitis is current…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
This clinical trial update from King's College London describes a non-invasive micro-suction device to collect skin biomarkers in babies wit…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Evaluate the Safety, Tolerability of BAT6026 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and tolerability of BAT6026 for atopic dermatitis; the study is currently active but not recr…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: PGE2/IL-22 Pathway in Various Forms of Eczema
NHS Lothian reports the completion of a clinical trial investigating the PGE2/IL-22 pathway in eczema. The study pertains to atopic dermatit…